ApprovalTrail

Approval · Notice of Compliance 7678 · 2006

LANOXIN: Notice of Compliance 7678

Issued January 11, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7678
Date
January 11, 2006
Company
Virco Pharmaceuticals (Canada) Co.Purdy'S Whaft Tower Ii, Halifax, Nova Scotia, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Cardiotonic glycoside

Products in this notice

BrandDINStatus today
LANOXINNot yet assigned—

Medicinal ingredients